142 related articles for article (PubMed ID: 2460952)
21. [Mepartricin in the treatment of benign prostatic hyperplasia].
Cirillo Marucco E; Pagliarulo A; Piccinno A; Di Rienzo U
Minerva Urol Nefrol; 1988; 40(2):101-4. PubMed ID: 2459784
[No Abstract] [Full Text] [Related]
22. [Mepartricin in the treatment of prostatic hypertrophy and correlated sexual disorders].
Buffa G; Brigato R; Cocimano V; Cevoli R; Marino G
Minerva Urol Nefrol; 1987; 39(2):121-4. PubMed ID: 2442818
[No Abstract] [Full Text] [Related]
23. [Therapeutic usefulness of mepartricin in benign prostatic hypertrophy: 2 years' experience. Preliminary note on the effect of mepartricin on certain possible etiopathogenic factors in benign prostatic hypertrophy].
Mirone V; Prezioso D; Palmieri A; Bocchini P
Minerva Urol Nefrol; 1988; 40(2 Suppl):16-7. PubMed ID: 2460938
[No Abstract] [Full Text] [Related]
24. [The effect of mepartricin on prostatic adenoma].
Pellet B; Granata F; von Niederhäusern W
Rev Med Suisse Romande; 1980 Nov; 100(11):899-903. PubMed ID: 6162182
[No Abstract] [Full Text] [Related]
25. [Mepartricin in the symptomatic therapy of prostatitis].
Rocco F; Franchini V
Minerva Urol Nefrol; 1988; 40(2 Suppl):67-9. PubMed ID: 3187842
[No Abstract] [Full Text] [Related]
26. [Therapeutic efficacy of mepartricin in the medical treatment of prostatic hypertrophy].
Virgili G; Mearini E; Sbarberi L; Camilli P; Costantini E
Minerva Med; 1986 May; 77(20):861-6. PubMed ID: 2425285
[TBL] [Abstract][Full Text] [Related]
27. [The role of mepartricin in the medical treatment of benign prostatic adenoma].
Casella G; Barbaro A
Arch Sci Med (Torino); 1978; 135(1):95-8. PubMed ID: 76466
[TBL] [Abstract][Full Text] [Related]
28. [Double-blind evaluation of mepartricin 150.000 U (40 mg) compared with placebo in benign prostatic hypertrophy].
Prezioso D; Mirone V; Fabrizio F; Lotti T
Minerva Urol Nefrol; 1996 Dec; 48(4):207-11. PubMed ID: 9005590
[TBL] [Abstract][Full Text] [Related]
29. [The effects of mepartricin on the symptomatology of prostatic hypertrophy--double-blind controlled trial].
Vanden Bossche M; Abi Aad A; Vandendris M; Van Cangh P; Schulman C
Acta Urol Belg; 1991; 59(1):93-104. PubMed ID: 1718154
[TBL] [Abstract][Full Text] [Related]
30. [Effect of treatment with mepartricin on the plasma androgen and gonadotropin concentrations in subjects with benign prostatic hypertrophy].
Sciarra F; Bianchi P; Toscano V
Minerva Urol Nefrol; 1988; 40(2 Suppl):10-2. PubMed ID: 2460936
[No Abstract] [Full Text] [Related]
31. The efficacy of bromocriptine in benign prostatic hypertrophy. A double-blind study.
Van Poppel H; Boeckx G; Westelinck KJ; Vereecken RL; Baert L
Br J Urol; 1987 Aug; 60(2):150-2. PubMed ID: 2444308
[TBL] [Abstract][Full Text] [Related]
32. Urodynamic and clinical effect of alpha-adrenergic blocker (phenoxybenzamine) in patients with benign prostatic hyperplasia.
Chen KK; Chang LS; Chen MT; Huang JK; Yin JH; Lin SN; Lin AD
Zhonghua Yi Xue Za Zhi (Taipei); 1988 Feb; 41(2):127-30. PubMed ID: 2458811
[No Abstract] [Full Text] [Related]
33. Assessment of the antihypercholesterolemic drug, Probucol, in benign prostatic hyperplasia.
Resnick MI; Jackson JE; Watts LE; Boyce WH
J Urol; 1983 Jan; 129(1):206-9. PubMed ID: 6186824
[TBL] [Abstract][Full Text] [Related]
34. Estrogen suppression as a pharmacotherapeutic strategy in the medical treatment of benign prostatic hyperplasia: evidence for its efficacy from studies with mepartricin.
Boehm S; Nirnberger G; Ferrari P
Wien Klin Wochenschr; 1998 Dec; 110(23):817-23. PubMed ID: 10025034
[TBL] [Abstract][Full Text] [Related]
35. [Mepartricin in the treatment of chronic prostatitis].
Borghi M; Cicchetti F
Minerva Urol Nefrol; 1988; 40(2 Suppl):62-4. PubMed ID: 3187840
[No Abstract] [Full Text] [Related]
36. [Mepartricin as medical treatment of benign prostatic hypertrophy].
Micali F; Giurioli A; Virgili G; Vespasiani G
J Urol (Paris); 1993; 99(6):293-5. PubMed ID: 7516370
[No Abstract] [Full Text] [Related]
37. Double-blind, placebo-controlled trial to assess the efficacy and tolerability of mepartricin in the treatment of BPH.
Denis L; Pagano F; Nonis A; Robertson C; Romano P; Boyle P
Prostate; 1998 Dec; 37(4):246-52. PubMed ID: 9831221
[TBL] [Abstract][Full Text] [Related]
38. [Effect of treatment with mepartricin on the concentrations of androgen receptors in adenomatous human prostatic tissue. Preliminary data].
Longo A; Fiorelli G; Rizzo M; Tosto A; Natali A; Forti G
Minerva Urol Nefrol; 1988; 40(2 Suppl):13-5. PubMed ID: 2460937
[No Abstract] [Full Text] [Related]
39. A 12-week placebo-controlled double-blind study of prazosin in the treatment of prostatic obstruction due to benign prostatic hyperplasia.
Chapple CR; Stott M; Abrams PH; Christmas TJ; Milroy EJ
Br J Urol; 1992 Sep; 70(3):285-94. PubMed ID: 1384919
[TBL] [Abstract][Full Text] [Related]
40. [Clinical pharmacologic aspects of mepartricin. Possible pharmacologic interference with digitaloids and anticoagulants].
Costa FV
Minerva Urol Nefrol; 1988; 40(2 Suppl):5-6. PubMed ID: 2460951
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
